Drug

Permethrin Cream 5% W/w

50 flagged reaction(s) · 781 total co-reports · max PRR 25.3

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Scratch	16	25.3	25.6	signal
2	Economic Problem	23	24.5	24.9	signal
3	Anhedonia	38	23.5	24.2	signal
4	Skin Infection	13	19.1	19.3	signal
5	Application Site Pain	24	17.9	18.2	signal
6	Skin Haemorrhage	15	17.0	17.2	signal
7	Incorrect Product Administration Duration	18	14.5	14.7	signal
8	Product Administered At Inappropriate Site	16	14.4	14.6	signal
9	Chronic Kidney Disease	66	14.1	14.8	signal
10	Osteopenia	13	14.0	14.1	signal
11	Application Site Pruritus	19	13.7	13.9	signal
12	End Stage Renal Disease	13	11.6	11.7	signal
13	Psoriatic Arthropathy	28	11.4	11.6	signal
14	Bone Density Decreased	20	10.3	10.5	signal
15	Nerve Injury	7	10.3	10.3	signal
16	Inappropriate Schedule Of Drug Administration	45	10.2	10.5	signal
17	Hair Texture Abnormal	8	9.7	9.8	signal
18	Decreased Activity	6	9.2	9.2	signal
19	Sleep Disorder Due To A General Medical Condition	9	9.1	9.2	signal
20	Drug Exposure During Pregnancy	19	9.0	9.1	signal
21	Bone Disorder	10	8.9	9.0	signal
22	Skin Disorder	18	8.9	9.0	signal
23	Drug Ineffective For Unapproved Indication	30	8.8	9.0	signal
24	Incorrect Route Of Product Administration	9	8.8	8.8	signal
25	Body Temperature Decreased	5	8.2	8.3	signal
26	Folliculitis	5	7.9	8.0	signal
27	Scab	5	7.2	7.2	signal
28	Application Site Rash	6	7.1	7.1	signal
29	Dry Skin	52	6.5	6.7	signal
30	Bone Loss	6	6.5	6.5	signal
31	Expired Product Administered	13	6.4	6.5	signal
32	Metastases To Central Nervous System	5	6.4	6.4	signal
33	Application Site Erythema	10	6.2	6.3	signal
34	Emotional Distress	46	6.2	6.4	signal
35	Burning Sensation	26	6.1	6.2	signal
36	Application Site Irritation	4	5.3	5.3	signal
37	Drug Toxicity	4	4.7	4.8	signal
38	Tooth Loss	6	4.7	4.7	signal
39	Incorrect Drug Administration Duration	8	4.6	4.6	signal
40	Psoriasis	36	4.5	4.6	signal
41	Rebound Effect	3	4.3	4.3	signal
42	Injection Site Discolouration	3	4.0	4.0	signal
43	Multiple Fractures	4	4.0	4.0	signal
44	Dermatitis Atopic	10	3.3	3.3	signal
45	Therapeutic Response Shortened	6	3.1	3.1	signal
46	Skin Burning Sensation	11	2.5	2.5	signal
47	Drug Effective For Unapproved Indication	4	2.2	2.2	no signal
48	Extrapyramidal Disorder	3	2.0	2.0	no signal
49	Accidental Exposure To Product	9	1.5	1.5	no signal
50	Drug Dependence	8	0.8	0.8	no signal